From: The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer
IHC CDCP1 | P valuea | ||
---|---|---|---|
Pos | Neg | ||
PDGFRβ tumor nest | |||
Pos (N = 29) | 21 (72.4%)b | 8 (27.6%) | 0.0429 |
Neg (N = 36) | 16 (44.4%) | 20 (55.5%) | |
PDGFRβ vascular lacunae | |||
Pos (N = 27) | 19 (70.4%) | 8 (29.6%) | 0.0795 |
Neg (N = 38) | 18 (47.4%) | 20 (52.6%) |